| Human liver FABP1 bound to tetrahydrocannabinol | | homo-2-mer | 1-127 | 100 | 2×MLI; 1×TCI; |
|
| Fabp protein after hv | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| Fabp ground state captured by XFELs | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| Intermediate of FABP with a delay time of 30 ns | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| Fabp protein before hv | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| A69C-M71L mutant of Fabp protein | | homo-2-mer | 2-127 | 99.21 | 2×PLM; |
|
| intermediate of FABP with a delay time of 100 ns | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| intermediate of FABP with a delay time of 300 ns | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| Intermediate of FABP with a delay time of 10 ns | | homo-2-mer | 2-127 | 97.62 | 2×PLM; |
|
| Crystal Structure of apo human FABP1 monoclinic form III | | monomer | 1-127 | 100 | 2×DMS; |
|
| Crystal Structure of apo human FABP1i monoclinic form II, twinned with beta=90deg | | monomer | 1-127 | 100 | |
|
| Crystal Structure of apo human FABP1 - monoclinic form I | | monomer | 1-127 | 100 | |
|
| Crystal Structure of apo human FABP1 - orthorhombic form | | monomer | 1-127 | 100 | |
|
| Crystal Structure of human FABP1 in complex with 2-[[4-cyclopropyl-5-methyl-3-[3-(trifluoromethyl)-… | | monomer | 1-127 | 100 | 1×VI9; 1×SCN; |
|
| Crystal structure of human fatty acid binding protein 1 (FABP1) | | monomer | 1-127 | 100 | |
|
| Crystal Structure of human FABP1 in complex with 2-[[3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-… | | monomer | 1-127 | 100 | 1×WII; 1×SCN; |
|
| NMR solution structure of wild type apo hFABP1 at 308 K | | monomer | 1-127 | 100 | |
|
| NMR solution structure of wild type hFABP1 with GW7647 | | monomer | 1-127 | 100 | 1×2VN; |
|
| NMR solution structure of wild type hFABP1 with GW7647 | | monomer | 1-127 | 100 | |
|
| Solution structure of human liver fatty acid binding protein | | monomer | 1-127 | 100 | |
|
| Structure of human LFABP at high resolution from S-SAD | | monomer | 2-127 | 100 | 2×PLM; |
|
| Iodide derivative of human LFABP at high resolution | | monomer | 2-127 | 100 | 2×PLM; 12×IOD; |
|
| Crystal Structure of human LFABP complex with two molecules of palmitic acid (holo-LFABP) | | monomer | 2-127 | 100 | 2×PLM; |
|
| Iodide derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 5×IOD; |
|
| Iodide derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 6×IOD; |
|
| Iodide derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 6×IOD; |
|
| Barium derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 2×BA; |
|
| Structure of human LFABP in complex with one molecule of palmitic acid | | monomer | 2-127 | 100 | 1×PLM; |
|
| Barium derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 2×BA; 4×IOD; |
|
| Cadmium derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 2×CD; |
|
| Iodide derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 5×IOD; |
|
| Iodide derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 5×IOD; |
|
| Cadmium derivative of human LFABP | | monomer | 2-127 | 100 | 2×PLM; 2×CD; |
|
| Structure of human LFABP (apo-LFABP) | | monomer | 2-127 | 100 | |
|
| Human L-FABP in complex with oleate | | monomer | 2-127 | 100 | 2×OLA; |
|
| Solution Structure of Human Apo L-FABP | | monomer | 2-127 | 100 | |
|
| Solution Structure of Human Holo L-FABP | | monomer | 2-127 | 100 | |
|